These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3085929)

  • 1. New perspectives in the treatment of Parkinson's disease.
    LeWitt PA
    Clin Neuropharmacol; 1986; 9 Suppl 1():S37-54. PubMed ID: 3085929
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Parkinson's disease.
    Lieberman A
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in the management of Parkinson's disease.
    Calne DB; Rinne UK
    Mov Disord; 1986; 1(3):159-62. PubMed ID: 3143065
    [No Abstract]   [Full Text] [Related]  

  • 4. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Kondo T
    J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonists as primary treatment in Parkinson's disease.
    Rinne UK
    Adv Neurol; 1987; 45():519-23. PubMed ID: 3103394
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological approaches to Parkinson's disease in the different phases of evolution.
    Giovannini P; Piccolo I; Scigliano G; Caraceni T
    J Neural Transm Suppl; 1986; 22():173-87. PubMed ID: 3097255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Parkinson's disease.
    Eadie MJ
    Aust Fam Physician; 1995 Sep; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of Parkinson's disease.
    Cohen MM; Scheife RT
    Am J Hosp Pharm; 1977 May; 34(5):531-8. PubMed ID: 326045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the treatment of Parkinson's disease.
    Wirz D
    Conn Med; 1985 Oct; 49(10):633-7. PubMed ID: 3933903
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on antiparkinsonian agents.
    Weiner M
    Geriatrics; 1982 Sep; 37(9):81-4, 89-91. PubMed ID: 6125455
    [No Abstract]   [Full Text] [Related]  

  • 11. MAO-B inhibitors in Parkinson's disease.
    Olanow CW
    Adv Neurol; 1993; 60():666-71. PubMed ID: 8420207
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug management of Parkinson's disease.
    Kishore A; Snow BJ
    Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic strategies in Parkinson's disease].
    Shoulson I
    Arch Neurobiol (Madr); 1991; 54(6):277-81. PubMed ID: 1687429
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant drugs in the treatment of on-off phenomena in Parkinson's disease.
    Csanda E; Tárczy M; Takáts A; Mogyorós I; Köves A; Bihari K
    Adv Neurol; 1984; 40():549-56. PubMed ID: 6421113
    [No Abstract]   [Full Text] [Related]  

  • 15. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
    Factor SA; Weiner WJ
    Mov Disord; 1993 Jul; 8(3):257-62. PubMed ID: 8341289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stage-adjusted treatment of idiopathic Parkinson syndrome].
    Ludin HP
    Wien Med Wochenschr; 1995; 145(13):294-8. PubMed ID: 7571654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Duvoisin RC; Mendoza MM; Yahr MD
    Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
    [No Abstract]   [Full Text] [Related]  

  • 18. Selegiline: a second look. Six years later: too risky in Parkinson's disease.
    Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent progress of therapy in patients with Parkinson's disease].
    Yanagisawa N
    Nihon Naika Gakkai Zasshi; 1993 Jul; 82(7):1109-14. PubMed ID: 8228492
    [No Abstract]   [Full Text] [Related]  

  • 20. Moderate Parkinson's disease. Strategies for maximizing treatment.
    Silverstein PM
    Postgrad Med; 1996 Jan; 99(1):52-4, 61-3, 67-8, passim. PubMed ID: 8539210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.